SMTL ID : 4jln.1

Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-PROPYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.15 Å
Oligo State
homo-dimer
Ligands
2 x 18V: 2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-PROPYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE(Non-covalent)
2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Nomme, J. et al., Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules. Acta Crystallogr.,Sect.D (2014)
Peptides
Deoxycytidine kinase: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Deoxycytidine kinase

Related Entries With Identical Sequence

4jlj.1 | 4jlk.1 | 4jlm.1 | 4kcg.1 | 4l5b.1 | 4q18.1 | 4q19.1 | 4q1a.1 | 4q1b.1 | 4q1c.1 | 4q1d.1 | 4q1e.1 | 4q1f.1